Kihara K et al Minimum incision endoscopic surgery (MIES) in Japanese Urology: results of adrenalectomy, radical nephrectomy and radical prostatectomy. Aktuelle Urologie 1. 2010; 41: S15-S19.

Kihara K, Kawakami S, Fujii Y, Masuda H, Koga F. Gasless single port access endoscopic surgery in urology: Minimum incision endoscopic surgery (MIES). Int J Urol. 16:791-800, 2009.PubMed

Kihara K, Kawakami S, Fujii Y, Masuda H, Koga F, Saito K. Gasless single port access radical nephrectomy. EAU Annual Congress, Stockholm, 2009/3/19.

Iimura Y, Kihara K, Saito K, Masuda H, Kobayashi T, Kawakami S. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma. Int J Urol. 15: 44-47, 2008.

Koga F, Kihara K, Kageyama Y, Kawakami S, Kobayashi T. Minimum incision endoscopic nephrectomy for giant hydronephrosis. Int J Urol. 14: 774-6, 2007

Sakura M, Kawakami S, Masuda H, Kobayashi T, Kageyama Y, Kihara K. Sequential bilateral minimum incision endoscopic radical nephretomy in dialysis patients with bilateral renal cell carcinomas. Int J Urol. 14: 1109-12, 2007

Kihara K. Minimum incision endoscopic urological surgery: Ship-in-a-bottle endoscopic urological surgery. The 8th triennial of the German-Japanese confederation of urology, Shizuoka, Apr 30, 2007

Kihara K. Minimum incision endoscopic urological surgery. Gasless International 2007, Special Lecture, Beijing, Dec 8, 2007

Kihara K, Kageyama Y, Yano M, Kobayashi T, Kawakami S, Fujii Y, Masuda H, Hyochi N.Portless endoscopic radical nephrectomy via a single minimum incision in 80 patients.Int J Urol.11:714-20, 2004

Kageyama Y, Kihara K, Kobayashi T, Kawakami S, Fujii Y, Masuda H, Yano M, Hyochi N.Protless endoscopic adrenalectomy via a single minimal incision using a retroperitoneal approach:experience with initial 30 cases.Int J Urol.11:693-9, 2004

Kawakami S, Takeshita H, Tatokoro M, Yamamoto S, Kijima T, Komai Y, Saito K, Numao N, Koga F, Fujii Y, Fukui I, Kihara K. Diagnostic performance of a three-dimensional 14-core systematic biopsy which can detect more than 95% of the prostate cancers detected by the three-dimensional 26-core super-extended biopsy scheme. EAU Annual Congress, Barcelona, 2010/4/17

Kubo Y, Kawakami S, Numao N, Takazawa R, Fujii Y, Masuda H, Tsujii T, Kihara K. Simple and effective local anesthesia for transperineal extended prostate biopsy: Application to the three-dimensional 26-core biopsy. Int J Urol. 16(4):420-423, 2009. PubMed

Suzuki M, Kawakami S, Asano T, Masuda H, Saito K, Koga F, Fujii Y, Kihara K. Safety of transperineal 14-core systematic prostate biopsy in diabetic men. Int J Urol. 16: 930-935, 2009. PubMed

Kawakami S. Repeat biopsy indicators: Novel nomograms based on extended repeat biopsy. EAU Annual Congress, Stockholm, 2009/3/20.

Numao N. Kawakami S, Fujii Y, Masuda H, Koga F, Sakai Y, Yonese J, Ishikawa Y, Fukui I, Kihara K. Candidate selection for focal targeted therapy with unilateral lobe by three-dimensional 26-core prostate biopsy. EAU Annual Congress, Stockholm, 2009/3/20.

Numao N. Kawakami S, Fujii Y, Masuda H, Koga F, Sakai Y, Yonese J, Ishikawa Y, Fukui I, Kihara K. Characterization of prostate cancers missed by transrectal 12-core biopsy. EAU Annual Congress, Stockholm, 2009/3/20.

Numao N.　Kawakami S, Fujii Y, Masuda H, Koga F, Sakai Y, Yonese J, Ishikawa Y, Fukui I, Kihara K. Characterization of prostate cancers missed by transrectal 12-core biopsy. “Best Poster Presentation”. EAU Annual Congress, Stockholm, 2009/3/20.

Kawakami S, Numao N, Okubo Y, Koga F, Yamamoto S, Saito K, Fujii Y, Yonese J, Masuda H, Kihara K, Fukui I. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur Urol. 54: 601-611, 2008.

Numao N, Kawakami S, Yonese J, Koga F, Saito K, Fujii Y, Ishikawa Y, Fukui I, Kihara K. Three-dimensional 26-core biopsy-based patient selection criteria for nerve-sparing radical prostatectomy. Int J Urol. 15: 1061-1066, 2008.

Numao N, Kawakami S. Reply to Rafael Boscolo-Berto, Antonio Galfano and Massimo Iafrate's Letter to the Editor re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved Accuracy in Predicting the Presence of Gleason Pattern 4/5 Prostate Cancer by Three-Dimensional 26-Core Systematic Biopsy. Eur Urol. 54: 471, 2008.

Kawakami S, Numao N, Yamamoto S, Yonese J, Fujii Y, Yokoyama M, Sakura M, Komai Y, Fukui I, Kihara K. Extended biopsy-based nomograms predicting prostate cancer on initial biopsy in men with PSA < 20 mg/mL. 2008 Genitourinary Cancers Symposium. San Francisco, USA, Feb 14, 2008.

Kawakami S, Koga F, Fujii Y, Saito K, Yamamoto S, Tatokoro M, Yonese J, Kageyama Y, Fukui I, Kihara K.History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.Int J Urol.15: 1055-1060, 2008.

Kawakami S, Okuno T, Yonese J, Igari T, Arai G, Fujii Y, Kageyama Y, Fukui I, Kihara K. Optimal Sampling Sites for Repeat Prostate Biopsy: A Recursive Partitioning Analysis of Three-Demensional 26-Gore Systematic Biopsy. Eur Urol, 51: 675-3, 2007

Kawakami S, Yamamoto S, Numao N, Ishikawa Y, Kihara K, Fukui I. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int J Urol. 14: 719-4, 2007

Numao N, Kawakami S, Yokoyama M, Yonese J, Arisawa C, Ishikawa Y, Ando M, Fukui I, Kihara K. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol, 52: 1663-8, 2007

Kawakami S, Numao N, Yonese J, Saito K, Koga F, Yamamoto S, Fujii Y, Kihara K, Fukui I. Three-dementional 26-core biopsy-based prediction model of low volume/low grade prostate cancer. 1st European Multidivplinary Meeting on Urological Cancers, Barcelona, Nov 3, 2007

Kawakami S, Yamamoto S, Fujii Y, Numao, N, Yonese J, Kihara K, Fukui I, Ishikawa Y. Direct comparion of cancer detectability between transrectal versus transperineal extended prostate biopsy. 1st European Multidivplinary Meeting on Urological Cancers. Barcelona, Nov 3, 2007

Numao N, Kawakami S, Yokoyama M, Yonese J, Ishikawa Y, Nakanishi Y, Arisawa C, Ando M, Fukui I, Kihara K. A prostate biopsy scheme optimal for both cancer detectability and grade accuracy. 22st Annual EAU congress, Berlin, Mar 22, 2007

Sakai Y, Okuno T, Kijima T, Iwai A, Matsuoka Y, Kawakami S, Kihara K. Simple prophylactic procedure of inguinal hernia after radical retropubic prostatectomy: Isolation of the spermatic cord.. Int J Urol. 16: 848-851, 2009. PubMed

Fujii Y, Yamamoto S, Yonese J, Kawakami S, Suyama T, Komai K, Kijima T, Kihara K, Fukui I. Novel technique to prevent post-radical retropubic prostatectomy inguinal hernia: the processus vaginalis transection method. 104th annual meeting of AUA (AUA 2009). Chicago, USA, 2009/4/28.

Fujii Y, Yamamoto S, Yonese J, Kawakami S, Okubo Y, Suyama T, Komai Y, Kijima T, Fukui I. Simple and east technique to prevent post-radical retropubic prostatectomy inguinal hernia, 29th congress of the societe internationale d’urologie. Paris, Sep 5, 2007

Koga F, Kihara K, Fujii Y, Yoshida S, Saito K, Masuda H, Kageyama Y, Kawakami S. Favourable outcomes of clinical stage T3NOMO bladder cancer patients treated with induction low-dose chemoradiotherapy plus partial or radical cystectomy versus immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 104: 189-194, 2009. PubMed

Inoue M, Ishioka J, Fukuda H, Kageyama Y, Saito Y, Higashi Y. Clinical outcome of chemoradiotherapy for T1G3 bladder cancer. Int J Urol. 15(8): 747-750, 2008.

Koga F, Yoshida S, Kawakami S, Kageyama Y, Yokoyama M, Saito K, Fujii Y, Kobayashi T, Kihara K. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intention-to-treat survival analysis. Urology 72: 384-388, 2008.

Koga F, Kawakami S, Yoshida S, Saito K, Fujii Y, Kihara K. Favorable outcomes of T3N0M0 bladder cancer patients treated with induction low-dose chemoradiotherapy plus partial or radical cystectomy compared to immediate radical cystectomy. 23rd annual EAU congress, Milan, Italy, March 26, 2008.

Koga F, Kawakami S, Yoshida S, Saito K, Fujii Y, Kihara K. Best poster presentation award in Poster Session 61: Treatment of advanced stage bladder cancer. Awarded by European Association of Urology, 2008.

Koga F, Yoshida S, Kageyama Y, Kawakami S, Fujii Y, Saito K, Masuda H, Kobayashi T, Kihara K. Induction low-dose chemoradiotherapy against muscle-invasive bladder cancer: Posssible improvement of survival and favorable local control for bladder preserved patients. SIU 29ｔｈ Congress of the societe Internationale d'Urologie, Paris, Sep 4, 2007

Tatokoro M, Fujii Y, Matsuoka Y, Komai F, Koga F, Saito K, Masuda H, Kawakami S, Kihara K. Phase II trial combination treatment of interferon-alfa, cimetidine, cyclooxygenase-2 inhibitor, and rennin-angiotensin system inhibitor in advanced renal cell carcinoma. American Society of Clinical Oncology, 2009 Genitourinary Cancers Symposium, USA, 2009/2/28.

Fujii Y, Tatokoro M, Saito K, Kihara K. Immunotherapy in era of targeted agents. The 8th international kidney cancer symposium. Chicago, USA, 2009/9/26.

Komai Y, Fujii Y, Okubo Y, Yamamoto S, Kawakami S, Yonese J, Fukui I. Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy. Int J Urol. 15: 971-975, 2008.

Tatokoro M, Fujii Y, Kawakami S, Fukui N, Komai Y, Saito K, Koga F, Morimoto S, Fukui I, Kihara K. Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: Report of three cases. Int J Urol. 5(9): 848-850, 2008.1

Fujii Y, Komai Y, Saito K, Iimura Y, Yonese J, Kawakami S, Ishikawa Y, Kumagai J, Kihara K, Fukui I.Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients.Urology72: 598-602, 2008.

Iimura Y, Saito K, Fujii Y, Kumagai J, Kawakami S, Komai Y, Yonese J, Fukui I, Kihara K. Development and External validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: The TNM-C score. J Urol. 181: 1004-1012, 2009. PubMed

Saito K, Tatokoro M, Fujii Y, Iimura Y, Koga F, Kawakami S, Kihara K. Impact of C-reactive Protein Kinetics on Survival of Patients With Metastatic Renal Cell Carcinoma. Eur Urol, 55:1145-53, 2009. PubMed

Iimura Y, Saito K, Fujii Y, Kumagai J, Komai Y, Tatokoro M, Kawakami S, Yonese J, Fukui I, Kihara K. Preoperative C-reactive protein is a significant factor of recurrence prediction model in patients with nonmetastatic clear cell renal cell carcinoma. 104th annual meeting of AUA (AUA 2009). Chicago, USA, 2009/4/28.

Tatokoro M, Saito K, Iimura Y, Fujii Y, Kawakami S, Kihara K. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. J Urol. 180: 515-519, 2008.

Yoshida S, Saito K, Koga F, Yokoyama M, Kageyama Y, Masuda H, Kobayashi T, Kawakami S, Kihara K. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 101: 978-981, 2008.

Iimura Y, Saito K, Tatokoro M, Fujii Y, Sakai Y, Koga F, Kobayashi T, Kawakami S, Kihara K. Preoperative C-reactive protein is a significant factor of prediction model for cancer specific survival in patients with clear cell renal cell carcinoma. 103th annual meeting of AUA (AUA 2008), Orlando, USA, May20, 2008.

Komai Y, Saito K, Sakai K, Morimoto S. Elevation of preoperative serum C-reactive protein level predict poor prognosis in localized renal cell carcinoma patients. BJU Int, 99:77-80, 2007

Saito K, Kawakami S, Ohtsuka Y, Fujii Y, Masuda H, Kumagai J, Kobayashi T, Kageyama Y, Kihara K. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int, 100:269-73, 2007

Saito K, Kawakami S, Ohtsuka Y, Fujii Y, Masuda H, Kumagai J, Kobayashi T, Kageyama Y, Kihara K. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. AUA 2007 annual meeting, Anaheim, May 20, 2007

Yoshida S, Saito K, Koga F, Kageyama Y, Yokoyama M, Matsuoka Y, Masuda H, Kobayashi T, Kawakami S, Kihara K. C-reactive Protein Predicts Prognosis of Muscle-invasive Bladder Cancer Patients Treated With Chemoradiotherapy. SIU 2007 annual meeting. Paris, Sep 4, 2007

Iimura Y, Saito K, Yokoyama M, Masuda H, Kobayashi T, Kawakami S, Kihara K.Preoperative C-reactive protein elevation as a predictor of localized renal cell carcinomaAUA 2007 annual meeting,Anaheim, May 21, 2007

Yokoyama M, Fujii Y, Yoshida S, Saito K, Koga F, Masuda H, Kobayashi T, Kawakami S, Kihara K. Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: A feasibility study. Int J Urol. 16: 61-63, 2009.PubMed

Sakura M, Kawakami S, Yoshida S, Masuda H, Kobayashi T, Kihara K. Prospective comparative study of single dose versus 3-day administration of antimicrobial prophylaxis in minimum incision endoscopic radical prostatectomy. Int J Urol. 15: 328-331, 2008.

Kobayashi T, Sakura M, Kawakami S, Yoshida S, Tatokoro M, Yokoyama M, Sakai Y, Koga F, Saito K, Fujii Y, Kihara K. Prospective comparative study of single intravenous versus single oral administration of antimicrobial prophylaxis in minimum incision endoscopic radical prostatectomy. 23rd annual EAU congress, Milan, Italy, March 26, 2008.

Saito K, Yoshida S, Yokoyama M, Sakura M, Sakai Y, Koga F, Masuda H, Fujii Y, Kobayashi T, Kawakami S, Kihara K. Absence of prophylactic antibiotics in minimum incision endoscopic surgery (MIES) of adrenal and renal tumour. 23rd annual EAU congress, Milan, Italy, March 26, 2008.

Yoshida S, Masuda H, Yokoyama M, Kobayashi T, Kawakami S, Kihara K. Absence of prophylactic antibiotics in minimum incision endoscopic urological surgery (MEUS) of adrenal and renal tumors. Int J Urol. 14: 384-7, 2007

Yoshida S, Koga F, Kawakami S, Ishii C, Numao N, Sakai Y, Saito K, Masuda H, Fujii Y, Kihara K. Initial Experience of Diffusion-weighted Magnetic Resonance Imaging to Assess Therapeutic Response to Induction Chemoradiotherapy against Muscle-invasive Bladder Cancer. Urology. 2010 Feb;75(2):387-91.

Yoshida S, Masuda, H, Ishii, C, Tanaka, H, Komai, Y, Numao, N, Saito, K, Koga, F, Fujii, Y, Kawakami, S, Kihara, K. Diffusion-weighted magnetic resonance imaging in diagnosis of upper urinary tract cancer. EAU Annual Congress, Barcelona, 2010/4/17

Kobayashi S, Yoshida S, Koga F, Ishii C, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Feasibility of diffusion-weighted magnetic resonance imaging in diagnosis of bladder cancer. EAU Annual Congress, Barcelona, 2010/4/17

Yoshida S. Kawakami S, Numao N, Ishii C, Tanaka H, Saito K, Koga F, Masuda H, Fujii Y, Kihara K. Multi-sequence magnetic resonance imaging prior to prostate biopsy：Correlation analysis using the pathological results of three-dimensional 26-core biopsy. EAU Annual Congress, Stockholm, 2009/3/20.

Yoshida S, Masuda H, Ishii C, Saito K, Kawakami S, Kihara K. Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging. Int J Urol. 15: 140-143, 2008.

Yoshida S, Masuda H, Ishii C, Numao N, Sakai Y, Saito K, Koga F, Fujii Y, Kobayashi T, Kawakami S, Kihara K. Functional imaging of upper urinary tract neoplasm by diffusion-weighted MRI. 23rd annual EAU congress, Milan, Italy, March 26, 2008.

Yoshida S, Masuda H, Ishii C, Matsuoka Y, Saito K, Kawakami S, Kihara K. Initial Experience of Functional Imaging of Upper Urinary Tract Urotherial Carcinoma By Diffusion-weighted. MRI SIU 2007 annual meeting, Paris, Sep 4, 2007

Minato Yokoyama, Yasuhisa Fujii, Yasumasa Iimura, Hitoshi Masuda, Satoru Kawakami, Kazunori Kihara.Estimated glomerular filtration rate after radical or partial nephrectomy in Japanese patients with renal cortical tumors. 104th annual meeting of AUA (AUA 2009).Chicago, USA, 2009/4/28.